SignatureFD’s Niagen Bioscience NAGE Stock Holding History

SignatureFD’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89K	Sell	592 -212	-26%	-$860	﹤0.01%	3141
2026 Q1	$3.55K	Buy	+804	New	+$4.34K	﹤0.01%	2891
2025 Q4	–	Sell	-44	Closed	-$411	–	3579
2025 Q3	$411	Hold	44	–	–	﹤0.01%	3222
2025 Q2	$634	Buy	+44	New	+$434	﹤0.01%	3074
2018 Q3	–	Sell	-8,000	Closed	-$30K	–	2020
2018 Q2	$30K	Hold	8,000	–	–	﹤0.01%	1041
2018 Q1	$34K	Buy	+8,000	New	+$41.9K	﹤0.01%	874

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SignatureFD's NAGE Position: Q2 2026 in Review

SignatureFD reduced its Niagen Bioscience (NAGE) stake by 26% in Q2 2026, selling an estimated $860 and leaving 592 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3141.

SignatureFD first reported a position in NAGE in Q1 2018 and has held it in 6 quarters since. The position peaked at $34K in Q1 2018. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

SignatureFD held 592 shares of Niagen Bioscience worth $1.89K as of Q2 2026.
SignatureFD sold 212 Niagen Bioscience shares in Q2 2026, an estimated $860.
Niagen Bioscience made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3141 holding.
SignatureFD first reported a position in Niagen Bioscience in Q1 2018 and has held it in 6 quarters since.
SignatureFD's Niagen Bioscience position peaked at $34K in Q1 2018.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.